ArticleBMC cancer2017

The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients.

Kenneth M K Mark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.